Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein
Authors
Keywords
Molecular docking, Protein expression, Caco-2 cells, Binding analysis, Apoptosis, Free energy, Small interfering RNAs, MTT assay
Journal
PLoS One
Volume 12, Issue 11, Pages e0187971
Publisher
Public Library of Science (PLoS)
Online
2017-11-10
DOI
10.1371/journal.pone.0187971
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells
- (2016) Wu Luo et al. Oncotarget
- Homology modelling of human P-glycoprotein
- (2015) L. Domicevica et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Demethoxycurcumin Modulates Human P-Glycoprotein Function via Uncompetitive Inhibition of ATPase Hydrolysis Activity
- (2015) Yu-Ning Teng et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- An in silico protocol for identifying potential poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors from chemical databases
- (2015) Miaomiao Niu et al. NEW JOURNAL OF CHEMISTRY
- The ability of molecular docking to unravel the controversy and challenges related to P-glycoprotein—a well-known, yet poorly understood drug transporter
- (2014) Maen Zeino et al. INVESTIGATIONAL NEW DRUGS
- Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: Herb–drug interactions mediated via P-gp
- (2014) Xue Li et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- In Silico Study of Desmosdumotin as an Anticancer Agent: Homology Modeling, Docking and Molecular Dynamics Simulation Approach
- (2013) Changdev Gadhe et al. Anti-Cancer Agents in Medicinal Chemistry
- Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine
- (2013) Fabian Müller et al. BIOCHEMICAL PHARMACOLOGY
- HZ08 inhibits the multi-drug resistance on multiple sites as the substrate of p-glycoprotein
- (2013) Yidong Feng et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Molecular Docking Characterizes Substrate-Binding Sites and Efflux Modulation Mechanisms within P-Glycoprotein.
- (2013) Ricardo J. Ferreira et al. Journal of Chemical Information and Modeling
- AZT and emodin exhibit synergistic growth-inhibitory effects on K562/ADM cells by inducing S phase cell cycle arrest and suppressing MDR1 mRNA/p-gp protein expression
- (2013) Peng Chen et al. PHARMACEUTICAL BIOLOGY
- Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia
- (2012) Stephany Corrêa et al. BMC CANCER
- Anti-inflammatory properties of anthraquinones and their relationship with the regulation of P-glycoprotein function and expression
- (2012) Ran Joo Choi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Can P-glycoprotein mediate resistance to nilotinib in human leukaemia cells?
- (2012) Petr Kosztyu et al. PHARMACOLOGICAL RESEARCH
- Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro
- (2011) DIAN-LEI LIU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Predicting Binding to P-Glycoprotein by Flexible Receptor Docking
- (2011) Elena Dolghih et al. PLoS Computational Biology
- Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
- (2009) S. G. Aller et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation